CCNU	ccnu	O	O
(	(	O	O
lomustine	lomustine	O	O
)	)	O	O
toxicity	toxicity	O	O
in	in	O	O
dogs	dogs	O	O
:	:	O	O
a	a	O	O
retrospective	retrospective	O	O
study	study	O	O
(2002	(2002	O	O
-	-	O	O
07).OBJECTIVE	07).objective	O	O
:	:	O	O
To	to	O	O
describe	describe	O	O
the	the	O	O
incidence	incidence	O	O
of	of	O	O
haematological	haematological	O	O
,	,	O	O
renal	renal	O	O
,	,	O	O
hepatic	hepatic	O	O
and	and	O	O
gastrointestinal	gastrointestinal	O	O
toxicities	toxicities	O	O
in	in	O	O
tumour-bearing	tumour-bearing	O	O
dogs	dogs	O	O
receiving	receiving	O	O
1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea	1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea	O	O
(	(	O	O
CCNU	ccnu	O	O
)	)	O	O
.	.	O	O

DESIGN	design	O	O
:	:	O	O
The	the	O	O
medical	medical	O	O
records	records	O	O
of	of	O	O
206	206	O	O
dogs	dogs	O	O
that	that	O	O
were	were	O	O
treated	treated	O	O
with	with	O	O
CCNU	ccnu	O	O
at	at	O	O
the	the	O	O
Melbourne	melbourne	O	O
Veterinary	veterinary	O	O
Specialist	specialist	O	O
Centre	centre	O	O
between	between	O	O
February	february	O	O
2002	2002	O	O
and	and	O	O
December	december	O	O
2007	2007	O	O
were	were	O	O
retrospectively	retrospectively	O	O
evaluated	evaluated	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
Of	of	O	O
the	the	O	O
206	206	O	O
dogs	dogs	O	O
treated	treated	O	O
with	with	O	O
CCNU	ccnu	O	O
,	,	O	O
185	185	O	O
met	met	O	O
the	the	O	O
inclusion	inclusion	O	O
criteria	criteria	O	O
for	for	O	O
at	at	O	O
least	least	O	O
one	one	O	O
class	class	O	O
of	of	O	O
toxicity	toxicity	O	O
.	.	O	O

CCNU	ccnu	O	O
was	was	O	O
used	used	O	O
most	most	O	O
commonly	commonly	O	O
in	in	O	O
the	the	O	O
treatment	treatment	O	O
of	of	O	O
lymphoma	lymphoma	O	S_disease
,	,	O	O
mast	mast	B_chemicals	B_disease
cell	cell	I_chemicals	I_disease
tumour	tumour	O	O
,	,	O	O
brain	brain	O	O
tumour	tumour	O	O
,	,	O	O
histiocytic	histiocytic	O	S_disease
tumours	tumours	O	O
and	and	O	O
epitheliotropic	epitheliotropic	O	O
lymphoma	lymphoma	O	S_disease
.	.	O	O

Throughout	throughout	O	O
treatment	treatment	O	O
,	,	O	O
56.9	56.9	O	O
%	%	O	O
of	of	O	O
dogs	dogs	O	O
experienced	experienced	O	O
neutropenia	neutropenia	O	S_disease
,	,	O	O
34.2	34.2	O	O
%	%	O	O
experienced	experienced	O	O
anaemia	anaemia	O	O
and	and	O	O
14.2	14.2	O	O
%	%	O	O
experienced	experienced	O	O
thrombocytopenia	thrombocytopenia	O	S_disease
.	.	O	O

Gastrointestinal	gastrointestinal	O	O
toxicosis	toxicosis	O	O
was	was	O	O
detected	detected	O	O
in	in	O	O
37.8	37.8	O	O
%	%	O	O
of	of	O	O
dogs	dogs	O	O
,	,	O	O
the	the	O	O
most	most	O	O
common	common	O	O
sign	sign	O	O
of	of	O	O
which	which	O	O
was	was	O	O
vomiting	vomiting	O	S_disease
(	(	O	O
24.3	24.3	O	O
%	%	O	O
)	)	O	O
.	.	O	O

Potential	potential	O	O
renal	renal	O	O
toxicity	toxicity	O	O
and	and	O	O
elevated	elevated	O	O
alanine	alanine	B_chemicals	O
transaminase	transaminase	S_chemicals	O
(	(	O	O
ALT	alt	O	O
)	)	O	O
concentration	concentration	O	O
were	were	O	O
reported	reported	O	O
in	in	O	O
12.2	12.2	O	O
%	%	O	O
and	and	O	O
48.8	48.8	O	O
%	%	O	O
of	of	O	O
dogs	dogs	O	O
,	,	O	O
respectively	respectively	O	O
.	.	O	O

The	the	O	O
incidence	incidence	O	O
of	of	O	O
hepatic	hepatic	O	B_disease
failure	failure	O	I_disease
was	was	O	O
1.2	1.2	O	O
%	%	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
CCNU-associated	ccnu-associated	O	O
toxicity	toxicity	O	O
in	in	O	O
dogs	dogs	O	O
is	is	O	O
common	common	O	O
,	,	O	O
but	but	O	O
is	is	O	O
usually	usually	O	O
not	not	O	O
life	life	O	O
threatening	threatening	O	O
.	.	O	O

